JUN TERUYA to Extracorporeal Membrane Oxygenation
This is a "connection" page, showing publications JUN TERUYA has written about Extracorporeal Membrane Oxygenation.
Connection Strength
3.855
-
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost. 2024 Feb; 50(1):81-90.
Score: 0.567
-
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods. Int J Lab Hematol. 2022 Jun; 44(3):589-594.
Score: 0.524
-
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2020 Feb; 46(1):62-72.
Score: 0.456
-
Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients: A Single Institution's Experience. Pediatr Crit Care Med. 2019 10; 20(10):980-985.
Score: 0.449
-
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2018 Feb; 44(1):20-29.
Score: 0.390
-
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
Score: 0.310
-
Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med. 2014 Feb; 15(2):178-9.
Score: 0.303
-
Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO. J Extra Corpor Technol. 2011 Jun; 43(2):64-9.
Score: 0.252
-
Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010 Dec; 134(6):950-4.
Score: 0.244
-
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. Ann Thorac Surg. 2022 03; 113(3):1026-1035.
Score: 0.130
-
C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII. Int J Lab Hematol. 2021 Feb; 43(1):139-142.
Score: 0.119
-
The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014 Nov; 138(11):1503-6.
Score: 0.080
-
Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood. Sci Rep. 2020 04 01; 10(1):5742.
Score: 0.029